Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Iscience
|
November 21, 2022
Adjuvants influence the maturation of VRC01-like antibodies during immunization
Maria L Knudsen, Parul Agrawal, Anna MacCamy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 3, 2014
Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization
Mark T Orr, Ryan M Kramer, Lucien Barnes, et al.
Infection and Immunity
|
July 16, 2014
Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis
Malcolm S Duthie, Rhea N Coler, John D Laurance, et al.
Parasites & Vectors
|
November 22, 2025
Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection
Ana Victoria Ibarra-Meneses, Laura Fernández, Juan Víctor San Martín, et al.
Science Translational Medicine
|
October 15, 2010
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis
Sylvie Bertholet, Gregory C Ireton, Diane J Ordway, et al.
NPJ Vaccines
|
October 11, 2018
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen
Neal Van Hoeven, Steven Wiley, Emily Gage, et al.
Plos One
|
February 23, 2016
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations
Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, et al.
The Journal of Experimental Medicine
|
June 19, 2002
Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection
Elizabeth G Rhee, Susana Mendez, Javeed A Shah, et al.
Journal of Internal Medicine
|
November 22, 2025
T cell-macrophage interactions in tuberculosis: What we've got here is failure to communicate
Rasmus Mortensen, Cecilia S Lindestam Arlehamn, Rhea N Coler, et al.
Plos One
|
February 8, 2011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant
Rhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Iscience
|
November 21, 2022
Adjuvants influence the maturation of VRC01-like antibodies during immunization
Maria L Knudsen, Parul Agrawal, Anna MacCamy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 3, 2014
Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization
Mark T Orr, Ryan M Kramer, Lucien Barnes, et al.
Infection and Immunity
|
July 16, 2014
Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis
Malcolm S Duthie, Rhea N Coler, John D Laurance, et al.
Parasites & Vectors
|
November 22, 2025
Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection
Ana Victoria Ibarra-Meneses, Laura Fernández, Juan Víctor San Martín, et al.
Science Translational Medicine
|
October 15, 2010
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis
Sylvie Bertholet, Gregory C Ireton, Diane J Ordway, et al.
NPJ Vaccines
|
October 11, 2018
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen
Neal Van Hoeven, Steven Wiley, Emily Gage, et al.
Plos One
|
February 23, 2016
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations
Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, et al.
The Journal of Experimental Medicine
|
June 19, 2002
Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection
Elizabeth G Rhee, Susana Mendez, Javeed A Shah, et al.
Journal of Internal Medicine
|
November 22, 2025
T cell-macrophage interactions in tuberculosis: What we've got here is failure to communicate
Rasmus Mortensen, Cecilia S Lindestam Arlehamn, Rhea N Coler, et al.
Plos One
|
February 8, 2011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant
Rhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, et al.
Page
of 14